Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension
NCT00667823
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
550
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG:
Macitentan
Sponsor
Actelion